Riskpilot← Back to searchSign inGet full accessOPUS LEGESENTER AS
ASActiveOrg 913846982Jærveien 12, 4319 SandnesGeneral medical practice activities · NACE 8621Est. 20144 employees
Revenue 2024
NOK 4,6M
+4% vs 2023
EBITDA margin
1.4%
-42% vs 2023
Equity ratio
37.6%
Financial strength
Net profit 2024
NOK 10K
+120% vs 2023
| Revenue | NOK 4,6M | +4% |
| EBITDA | NOK 66K | -42% |
| Net profit | NOK 10K | +120% |
| Total assets | NOK 1,7M | +54% |
| Equity | NOK 628K | +2% |
| Employees | 4 | — |
Legal name
OPUS LEGESENTER AS
Org number
913846982
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
3. juli 2014
Share capital
NOK 600 000
Employees
4 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap.
Company purpose
Drift av legesenter. Stille utstyr og personell til rådighet for leger tilknyttet senteret. Handel, hva dermed står i forbindelse, samt deltakelse i andre selskaper med lignende formål.
Address
Jærveien 12, 4319 Sandnes
Phone
+4751687850
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 3 515 | 3 850 | 4 228 | 4 406 | 4 604 |
| Staff expenses | −1 447 | −1 624 | −1 852 | −1 894 | −1 968 |
| EBITDA | 70 | 101 | 103 | 114 | 66 |
| Depreciation & amort. | −68 | −99 | −106 | −114 | −66 |
| EBIT | 2 | 1 | −2 | −0 | −0 |
| Net financials | −0 | 0 | −0 | 6 | 13 |
| Profit before tax | 1 | 1 | −2 | 6 | 13 |
| Tax | 0 | 0 | −1 | 1 | 3 |
| Net profit | 1 | 1 | −2 | 5 | 10 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 162 | 1 242 | 1 139 | 1 088 | 1 672 |
| Equity | 614 | 616 | 614 | 618 | 628 |
| Long-term debt | 9 | 8 | 1 | 0 | 0 |
| Short-term debt | 538 | 619 | 524 | 469 | 1 044 |
| Total debt | 547 | 627 | 525 | 469 | 1 044 |
EBITDA margin
1.4%
This company
15.8%
Market median
-91% vs market
20202024
Equity ratio
37.6%
This company
38.2%
Market median
+2% vs market
20202024
Return on equity
1.6%
This company
18.4%
Market median
-91% vs market
20202024
Net profit margin
0.2%
This company
8.1%
Market median
-98% vs market
20202024
Asset turnover
2.75×
This company
1.12×
Market median
+146% vs market
20202024
Debt / equity
1.66×
This company
0.62×
Market median
-168% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
IV Chief Executive Officer | Chief Executive Officer | 2014 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2021 | |
| Board of Directors | 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 16.67% | 16.67% | 2023 | |
| Individual | 16.67% | 16.67% | 2023 | |
| Individual | 16.67% | 16.67% | 2023 | |
| Individual | 16.67% | 16.67% | 2023 | |
| Individual | 16.67% | 16.67% | 2022 | |
| Individual | 16.67% | 16.67% | 2023 | |
| Individual | 16.67% | 16.67% | 2023 | |
| Individual | 16.67% | 16.67% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of OPUS LEGESENTER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ingvild Vatten Alsnes | Chief Executive Officer | 0 companies |
| Henrik Solvang | Board of Directors | 0 companies |
| Bjørg Marie Vabø Sætermo | Board of Directors | 0 companies |